Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
WisdomTree US MidCap Fund
EZM
$940M
| $5.16M | ﹤0.01% |
171,942
-1,257
| -0.7% | -$34.9K |
|
|
RENX
2677
DELISTED
RELX N.V.
RENX
| $5.16M | ﹤0.01% |
294,043
+60,439
| +26% | +$998K |
|
2678
Cognex
CGNX
$10.9B
| $5.15M | ﹤0.01% |
264,348
+163,398
| +162% | +$2.85M |
|
|
XLRN
2679
PUT
DELISTED
Acceleron Pharma
XLRN
| $5.15M | ﹤0.01% |
195,000
+45,000
| +30% | +$1.31M |
|
2680
PUT
Cracker Barrel
CBRL
$1.26B
| $5.14M | ﹤0.01% |
33,700
+29,300
| +666% | +$4.04M |
|
2681
PUT
Generac Holdings
GNRC
$11.6B
| $5.14M | ﹤0.01% |
138,100
-115,100
| -45% | -$3.71M |
|
2682
PUT
iShares MSCI Hong Kong ETF
EWH
$1.24B
| $5.14M | ﹤0.01% |
260,100
+229,900
| +761% | +$4.21M |
|
2683
CALL
Deckers Outdoor
DECK
$13.2B
| $5.14M | ﹤0.01% |
514,800
+166,200
| +48% | +$1.44M |
|
2684
Matador Resources
MTDR
$6.2B
| $5.13M | ﹤0.01% |
270,775
+35,090
| +15% | +$582K |
|
|
AERI
2685
DELISTED
Aerie Pharmaceuticals
AERI
| $5.12M | ﹤0.01% |
420,961
+398,512
| +1,775% | +$6.31M |
|
|
MORE
2686
DELISTED
Monogram Residential Trust, Inc.
MORE
| $5.12M | ﹤0.01% |
519,064
-70,131
| -12% | -$640K |
|
|
DWIN
2687
DELISTED
Invesco DWA Tactical Multi-Asset Income ETF
DWIN
| $5.11M | ﹤0.01% |
+200,000
| New | +$5.07M |
|
|
PTLA
2688
CALL
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.1M | ﹤0.01% |
+250,000
| New | +$7.93M |
|
|
PTLA
2689
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.1M | ﹤0.01% |
+250,000
| New | +$7.93M |
|
2690
CALL
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $5.09M | ﹤0.01% |
229,600
-4,018,800
| -95% | -$83M |
|
2691
Brink's
BCO
$4.88B
| $5.08M | ﹤0.01% |
151,358
+100,854
| +200% | +$2.97M |
|
|
WIN
2692
DELISTED
Windstream Holdings Inc
WIN
| $5.08M | ﹤0.01% |
132,348
-62,222
| -32% | -$2.02M |
|
2693
CALL
Best Buy
BBY
$18.2B
| $5.06M | ﹤0.01% |
156,100
-712,400
| -82% | -$21.6M |
|
2694
PUT
Equinix
EQIX
$101B
| $5.06M | ﹤0.01% |
15,300
-480,941
| -97% | -$146M |
|
2695
CALL
Hewlett Packard
HPE
$63.4B
| $5.06M | ﹤0.01% |
490,703
-9,257,458
| -95% | -$77.6M |
|
2696
Fossil Group
FOSL
$293M
| $5.04M | ﹤0.01% |
113,567
-20,303
| -15% | -$801K |
|
2697
Nektar Therapeutics
NKTR
$2.39B
| $5.04M | ﹤0.01% |
24,462
-6,349
| -21% | -$1.22M |
|
2698
LCI Industries
LCII
$2.49B
| $5.04M | ﹤0.01% |
78,246
+73,390
| +1,511% | +$4.31M |
|
2699
iShares Morningstar Value ETF
ILCV
$1.32B
| $5.03M | ﹤0.01% |
119,806
+52
| +0% | +$2.08K |
|
2700
First Citizens BancShares
FCNCA
$24.9B
| $5.02M | ﹤0.01% |
19,979
-11,227
| -36% | -$2.7M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.